These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 21150132)

  • 1. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
    Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
    Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
    Leung TM; Nieto N
    J Hepatol; 2013 Feb; 58(2):395-8. PubMed ID: 22940046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.
    Abdelmegeed MA; Banerjee A; Jang S; Yoo SH; Yun JW; Gonzalez FJ; Keshavarzian A; Song BJ
    Free Radic Biol Med; 2013 Dec; 65():1238-1245. PubMed ID: 24064383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?
    Bode C; Bode JC
    Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):166S-71S. PubMed ID: 16344604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
    Ceni E; Mello T; Galli A
    World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
    Boye A; Zou YH; Yang Y
    World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness.
    Forsyth CB; Voigt RM; Keshavarzian A
    Redox Biol; 2014; 3():40-6. PubMed ID: 25462064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.
    Sutti S; Bruzzì S; Albano E
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):243-53. PubMed ID: 26634783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of oxidative stress in alcoholic liver injury].
    Radosavljević T; Mladenović D; Vucević D
    Med Pregl; 2009; 62(11-12):547-53. PubMed ID: 20491381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does oxidative stress participate in the development of hepatocellular carcinoma?
    Sasaki Y
    J Gastroenterol; 2006 Dec; 41(12):1135-48. PubMed ID: 17287893
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-inflammatory strategies in alcoholic steatohepatitis.
    Enomoto N; Takei Y; Yamashina S; Ikejima K; Kitamura T; Sato N
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S59-61. PubMed ID: 17567468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease.
    Yang YM; Cho YE; Hwang S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and Fibrosis.
    Mueller S; Peccerella T; Qin H; Glassen K; Waldherr R; Flechtenmacher C; Straub BK; Millonig G; Stickel F; Bruckner T; Bartsch H; Seitz HK
    Alcohol Clin Exp Res; 2018 Feb; 42(2):252-259. PubMed ID: 29120493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease.
    Tsedensodnom O; Vacaru AM; Howarth DL; Yin C; Sadler KC
    Dis Model Mech; 2013 Sep; 6(5):1213-26. PubMed ID: 23798569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic stellate cells and innate immunity in alcoholic liver disease.
    Suh YG; Jeong WI
    World J Gastroenterol; 2011 May; 17(20):2543-51. PubMed ID: 21633659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytokines and chemokines in the development of steatohepatitis.
    Lalor PF; Faint J; Aarbodem Y; Hubscher SG; Adams DH
    Semin Liver Dis; 2007 May; 27(2):173-93. PubMed ID: 17520517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
    Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
    J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.